Review
Tobacco exposure, a diet high in cholesterol and genetic predisposition to elevated lipids has been linked to premature atherosclerosis, cardiovascular diseases, cardiovascular disability, and death [1, 2] . Until now, the primary hypothesis that linked elevated cholesterol to such dysfunction has been vascular, mainly focusing on the development of atherosclerotic changes in the blood vessels. However, new findings suggest that heart muscle can develop dysfunctional Ca 2+ cycling leading to cell death from elevated levels of serum cholesterol derivatives, the oxysterols, which already were demonstrated to contribute to the development of such diseases as age-related macular degeneration, Alzheimer's disease, and osteoporosis [3] .
Macrophages play a central role in atherogenesis due to the accumulation of cholesterol, and the production of inflammatory mediators and cytokines. Recently, macrophages and macrophage-derived 'foam cells' were also demonstrated to produce oxysterols, which can induce apoptosis of macrophages themselves, as well as in neighboring endothelial and smooth muscle cells [4, 5] . In advanced lesions, this promotes the development of the necrotic core, a key factor leading to acute luminal thrombosis [6] .
When macrophage oxysterols are released directly to coronary arteries, they could also reach harmful levels in cardiac cells. However, the effects of oxysterols on cardiac myocytes remain largely unknown. The purpose of this article is to discuss the possible mechanisms underlying effects of oxysterols in cardiac myocytes. Based on the ana lysis of effects of oxysterols on smooth muscle cells and our preliminary data concerning effects of oxysterols on Ca 2+ signaling in ventricular myocytes [7] , the article discusses some possible mechanisms of such effects. For detailed reviews of oxysterols, their nomenclature, generation, and biological effects see Brown and Jessup [8] , Schroepfer [4] , and Vejux et al. [3] .
Oxysterols
Oxysterols are biologically active molecules generated during the oxidation of cholesterol. There are two mechanisms for oxysterol production: autoxidation and enzymatic oxidation. In cholesterol, the most sensitive positions for autoxidation are 4, 5, 6 and 7 ( Figure 1 ) [3] . It is now widely accepted that oxysterols resulting from enzymatic synthesis are 7a-, 24S-, 25-and 27-hydroxycholesterols [3, 4, 9] .
In the plasma lipophilic oxysterols are transported mainly by low-density lipoproteins (LDLs) and, probably, by albumin [3] . Although cholesterol itself is not toxic [2, 10, 11] , some cholesterol oxides, 7-ketocholesterol, a-TRIOL (cholestan-3b,5a,6b-triol), 7b-hydroxycholesterol, and 25-hydroxycholesterol, have been demonstrated to injure vascular endothelial and smooth muscle cells [12] [13] [14] [15] [16] . Notably, 25-hydroxycholesterol is one of the most toxic agent in the group [12, 13, 17] .
25-hydroxycholesterol and 27-hydroxycholesterol were found in alveolar, peritoneal and testicular macrophages and in macrophagederived 'foam cells' from atherosclerotic tissue [9, 11, 13, [18] [19] [20] . Although the mechanisms of future science group Review Lukyanenko & Lukyanenko accumulation of other oxysterols in 'foam cells' remains mostly unknown, 25-hydroxycholesterol was demonstrated to be produced in macrophages through 25-hydroxylation of cholesterol by 25-hydroxylase [20, 21] (for oxysterols in other tissues see [3, 4, 9, 22] ). In regard to the production mechanisms of other oxysterols found in 'foam cells', it is important to consider the paper by Zarev et al. [23] . The authors demonstrated the weak ability of •OH/O 2 • -free radicals to initiate oxidation of cholesterol in LDLs. This suggests that they could be p roduced primarily in the same (enzymatic) way as 25-hydroxycholesterol in macrophages.
The reason why macrophages produce oxysterols remains unknown. It has been suggested that such hydroxylation of cholesterol (Figure 1) to oxygenated sterols could serve to remove cholesterol from the cell and transport it to the liver for excretion [4, 9, 24, 25] . However, oxysterols were also shown to regulate multiple physiological functions. For instance, testicular macrophages produce 25-hydroxycholesterol to stimulate steroidogenesis in Leydig cells through a steroidogenic acute regulatory protein-independent pathway [20, 26] . Lipophilic oxysterols easily penetrate cell membranes [3, 8, 9, 20, 26, 27] and, therefore, can diffuse from macrophages (or 'foam cells') into the surrounding endothelial, smooth muscle and cardiac cells.
Reported plasma oxysterol levels in apparently healthy humans depend on sample freshness, assay method and cholesterol levels [4, 8, 28, 29] . In fresh samples levels can vary between tens and hundreds of nanomoles [4] . Increased plasma concentrations of oxysterols were demonstrated to be associated with an increased risk of atherosclerosis, cardiovascular disease, and diabetes [3,4,8,29- The release of Ca 2+ from the sarcoplasmic reticulum (SR) is a critical process in the normal physio logy of cardiac myocytes. SR Ca 2+ cycling is a balance between Ca 2+ release and uptake [36] [37] [38] . In adult mammalian cardiac myocytes, the SR serves as the intracellular Ca 2+ pool for the regulation of cardiac contraction [39, 40] . Figure 2 shows the ultrastructure of cardiac myocytes. Ca 2+ release occurs in the cleft between the SR and sarcolemma of a T-tubule, which is enriched SR Ca 2+ release channels termed, ryanodine receptors (RyRs). The close proximity of the SR to the sarcolemma suggests that oxysterols could also be involved in the r egulation of SR Ca 2+ cycling. Figure 1 . Chemical structures of cholestan (with numbering system) and its derivatives, cholesterol and one of the most toxic oxysterols, 7-hydroxycholesterol. For more structures of oxysterols see [3, 8] .
future science group Defective SR Ca 2+ cycling was found to be responsible for defective excitation-contraction coupling in heart failure [54] [55] [56] [57] [58] [59] [60] [61] [62] and was demonstrated to lead to a variety of cardiac dysfunctions. For example, spontaneous Ca 2+ release and increased SR Ca 2+ leak has been implicated in genetic and acquired triggered arrhythmias and the initiation of ventricular fibrillation during postischemic reflow [60, 61, [63] [64] [65] [66] [67] [68] [69] [70] [71] .
We conclude that the data from the literature on arterial smooth muscle cells and our recent experiments in cardiac myocytes suggest a direct inhibitory effect of oxysterols on the SR Ca 2+ uptake.
Atherosclerosis
Atherosclerosis is a life-threatening disease that affects critical organs including the heart and brain [72] . Atherosclerotic plaques (deposits of fatty substances, cholesterol, cellular waste products, calcium and other substances in the inner lining of an artery) usually affect large and medium-sized arteries, including coronary arteries (coronary atherosclerosis; [73] ). Atherosclerosis and its complications, such as coronary heart disease, ischemic heart disease, heart failure, heart infarction and stroke, are the primary causes of death in Western c ountries [1, 74, 75] . While the precise steps leading to atherosclerosis remain elusive [2] , postulated steps in atherogenesis show a critical role for inflammation in the development of the 'fatty streak', progressive atherosclerotic lesions, and the development of an occlusive thrombus [75] [76] [77] [78] . In short, blood monocytes traverse the endothelial intercellular space and are deposited in the subendothelial layers where they are transformed into macrophages. During the various stages of atherogenesis the number of macrophages in the 'fatty streak' could increase due to the expression of various cytokines, which are potent chemoattractants for inflammatory cells including macrophages [76] . The formation of oxysterols owing to the oxidation of the cholesterol-rich LDL accelerates the uptake of cholesterol into macrophages, thereby leading to the next step -the formation of the cholesterol-laden 'foam cell' [12, 76, 79] .
It is notable that oxysterols induce apoptosis of macrophages themselves and in neighboring endothelial and smooth muscle cells [4, 5] promoting the development of the necrotic core, a key factor leading to acute luminal thrombosis [6] . Although functional effects of oxysterols on noncardiac muscle cells have been described very well, the underlying mechanisms of the effects and the role of oxysterols in the development of atherosclerosis-related heart failure r emain largely unknown.
Heart failure
Heart failure is a syndrome with many different well-described causes, including myocardial infarction, pressure overload, volume overload, viral myocarditis, toxic cardiomyopathy, mutations in genes encoding for sarcomeric or cytoskeletal proteins, and valve diseases [59] .
Heart failure develops when the amount of blood pumped from the heart is inadequate to meet the metabolic demands of the body [59, 80] . Although the later stages of the disease are well Reproduced with permission from [120] .
future science group Review Lukyanenko & Lukyanenko characterized (hypertrophy, and abnormal excitation-contraction coupling and Ca 2+ handling; for reviews see refs. [59, 74] ), the starting stages of heart failure are not specifically related to specific pathological processes and are usually characterized just as depressed contractility [80] . In the case of atherosclerosis, the primary mechanism inducing the cascade of events leading to heart failure has not been identified.
Some studies suggest that the primary mechanism could be related to macrophage oxysterols. Blum and Miller [81] and later Tomaselli and Zipes [74] demonstrated that inflammatory processes are directly involved in cardiac depression and in the complex syndrome of heart failure. Also, oxysterols have been demonstrated to be involved in the pathogenesis of the early stages of atherosclerosis [2] . Similar to atherosclerotic complications described for smooth muscle cells, the effect of oxysterols on cardiomyocytes could be mediated by mitogen-activated protein kinases (MAPKs). Indeed, activation of the p38 MAPK was demonstrated to cause deleterious cardiac contractile dysfunction by decreasing myofilament response to Ca 2+ [82] through downregulation of SERCA expression [83] and/ or via p38-dependent production of reactive oxygen species [84] . However, the last statement is contrary to the widely accepted hypothesis that p38 MAPK activation enhances cardiac myocyte survival in response to apoptotic stimuli [85] . This paper suggests that, at least in the case of atherosclerosis-induced heart failure, the onset of dysfunction could be initiated by the direct effects of oxysterols on the mechanisms underlying SR Ca 2+ cycling and/or by regulating the activity of MAPKs. Indeed, the abnormalities in Ca 2+ handling during heart failure (such as an increase in resting [Ca 2+ ] cyt [86] ) are similar to those caused by oxysterols. Thus, the increasing effect of the oxysterols on cytosolic [Ca 2+ ] could eventually result in MAPK-induced cell death [87] .
Oxysterol-induced changes in cell ultrastructure & function
It is now widely accepted that oxysterols have cytotoxic and proinflammatory effects [3, 4, 34, 88] . The quantification of oxysterols in LDL extracts and the comparison with the toxicity of authentic standards indicate that some of them are also present at levels harmful to muscle cells [9, 89] . Indeed, oxysterols were demonstrated to have strong effects on the surrounding cells. These effects include: reduction in lipoprotein lipase mRNA and decrease in lipoprotein lipase activity; downregulation of Bcl-2 expression; activation of caspases; degradation of poly(ADPribose) polymerase -a substrate for caspase 3 and a key enzyme involved in genome surveillance and DNA repair; production of reactive oxygen species; opening of mitochondrial permeability transition pore; activation of glycogen synthase [2, 3, 11, [13] [14] [15] [16] 32, 34, 77, [89] [90] [91] [92] [93] [94] [95] . The effects could be divided into two groups: short-term effects on cell physiology and long-term effects that involve changes in cell morphology and lead to cell death.
Effects of oxysterols on cell physiology
Lipophilic oxysterols are able to enter intracellular membranes and affect the structure and function of membrane-associated proteins [8] . In aortic smooth muscle cells 10 µM 7b-hydroxycholesterol and 25-hydroxycholesterol were shown to inhibit activities of Na + -K + -ATPase, 5´-nucleotidase, and SERCA [32, 96] channel blocker nifedipine, and the authors concluded that oxysterols affect membrane Ca 2+ channels. However, the nifedipine-sensitive channels (dihydropyridine receptor or l-type Ca 2+ channels) are also major channels for replenishing SR Ca 2+ . Therefore, by inhibiting the major membrane Ca 2+ input by nifedipine, the authors s ignificantly reduced the SR Ca 2+ load. Although cell membranes can accumulate oxysterols, and at high concentrations (~100 µM) oxysterols induce a lactate dehydrogenase leak through cardiac membranes [27] , it is very doubtful that they affect voltage-dependent dihydropyridine-sensitive Ca 2+ channels [97] . Indeed, Ares et al. [15] demonstrated that although the effects of 7b-hydroxycholesterol were dependent on extracellular [ [98, 99] . Therefore, an increase in [Ca 2+ ] cyt could be a major factor inducing oxysterol-related changes in morphology (remodeling) of cardiomyocytes and/or cell death.
Effects of oxysterols on cell morphology
Long-term (hours) exposure to oxysterols was demonstrated to cause alterations in cell morphology [14, 15, 92] and cell death [2, 16, 34, [89] [90] [91] . There are three types of cell death with characteristic morphological aspects: type 1 (apoptosis); type 2 (autophagy) and type 3 (oncosis or necrosis) [100] . In different cell types oxysterols induce both apoptosis and oncosis (necrosis) [3, 16, 101, 102] . Mechanisms of apoptosis induced by oxysterols and the proportions of cells exhibiting apoptotic or oncotic responses depend on the cell type and the particular oxysterol. It is important to note that some oxysterols are capable of inflicting oncotic death by lysis in a matter of hours [16] .
The type of muscle cell death associated with oxysterol treatment tends to be apoptotic (i.e., has more apoptic than oncotic changes) [101] . However, autophagic cell death of human aortic smooth muscle cells treated with 7-ketocholesterol has also been reported [103] . The first changes in smooth muscle cell ultrastructure were visible within 4 h of incubation with 25 µM 25-hydroxycholesterol [14] : chromatin condensation, an increased number of lysosomes and the emergence of arrays of tubular future science group Review Lukyanenko & Lukyanenko membrane structures. After 24 h of treatment by different oxysterols, the cells began to lose ordered SR and Golgi membranes and to display blebs [14, 15] . General swelling, a distinct feature of oncotic cell death, was not observed in the cells treated with oxysterols. It is not known whether the apparent loss of organized SR and Golgi membranes is a characteristic of apoptosis in oxysterol-induced cell death. However, swelling does not seem to be a dominant feature of these changes. Thus, despite the lack of some apoptotic features (such as budding and karyorhexis) oxysterol-induced cell death looks more apoptotic than oncotic. Recently, using in situ DNA fragmentation assay, Saito et al. [35] confirmed this finding in vascular smooth muscle cells.
Future perspective Gaps in our understanding of the mechanisms involved in atherogenesis
Although coronary heart disease, ischemic heart disease, heart infarction and heart failure are among the most common complications of atherosclerosis, the specific mechanisms inducing the complications remain unknown. The primary consequence hypothesis that links elevated cholesterol to such dysfunction has been vascular, mainly focusing on the development of atherosclerotic changes in the local blood flow [78] . However, recent advances in the basic sciences have established a fundamental role for inflammation in mediating all stages of atherosclerosis from initiation through progression and, ultimately, the thrombotic complications of atherosclerosis. These new findings provide important links between risk factors and the mechanisms of atherogenesis [78] .
Elevation of inflammation markers predicts the outcomes of patients with acute coronary syndromes, and certain treatments that reduce coronary risk are also known to reduce inflammation. However, in the case of lowering lipids with statins, this anti-inflammatory effect does not appear to correlate with a reduction in LDL levels [78] (see [2] ). While theoretically compelling, and supported by a considerable body of experimental evidence, the relevance of the LDL oxidation hypothesis to human atherosclerosis remains unproven [78] . Thus, one of the unresolved issues is the relationship between LDL oxidation and the inflammatory theories in explaining the complications of atherosclerosis. However, LDL oxidation and inflammation are two facets of a single pathogenesis and we suggest that macrophage oxysterols can link these hypotheses [2] . Indeed, oxysterols could be produced in the inflammatory cells from o xidation of cholesterol. Oxysterols in heart failure Review to freely defuse from macrophages and could affect multiple cell functions near the a therosclerotic core region.
Analysis of the literature and our preliminary data allow us to suggest that the major pathway for the effect of oxysterols involves an increase in diastolic [Ca 2+ ] in the cytoplasm of cardiomyocytes through Ca 2+ empting of the SR followed by compensatory expression of additional Ca 2+ channels into sarcolemma [7] . Figure 4 demonstrates the putative pathways for the effect of oxysterols leading to cardiomyocyte malfunction and death. Early on, macrophages create a local but deleterious concentration of oxysterols. These diffuse into cardiomyocytes, induce a reduction in SERCA activity and increase cytoplasmic [Ca 2+ ]. The effectiveness of this elevation of cytoplasmic [Ca 2+ ] depends on the oxysterol concentration and the timing. It is very doubtful that this first wave of cytoplasmic Ca 2+ (marked with 1 in the circle) will be directly involved in cardiomyocyte remodeling and/or death. However, in the case of sustained exposure to oxysterols, it could activate mechanisms leading to cell hypertrophy and/or death. First of all, Ca 2+ could activate production of reactive oxygen species (ROS). Although some authors are skeptical regarding the role for oxysterol-induced ROS in atherosclerosis [78] , others consider ROS to be a major factor in oxysterolrelated cell damage [3] . Indeed, although low levels of ROS drive diverse and important cellular functions, excessive ROS generation leads to both apoptotic and oncotic cell death [104] [105] . This effect of oxysterols on ROS production was demonstrated to be mediated by high mitochondrial [Ca 2+ ] [105, 107, 108] , which results from an increase in cytoplasmic [Ca 2+ ] [109] . However, mechanisms of initiation of apoptosis by ROS are not clear yet. ROS can: first, directly injure cell membranes and cause cell death; second, enhance the disruption of the mitochondrial membrane due to mitochondrial Ca 2+ overload; or third, induce apoptosis associated with activation of MAPKs [108, [110] [111] [112] [113] . Considerable work needs to be done in order to understand the relationship between ROS, oxysterols and calcium signaling in heart disease, but the initial evidence is exciting.
Another way to induce cell hypertrophy and/or death could depend on subsequent waves of increased cytoplasmic [Ca 2+ ]. Corresponding pathways are marked with numbers in circles on Figure 4 . Oxysterol-induced SR Ca 2+ emptying activates compensatory expression of sarcolemmal Ca 2+ channels and Na + /Ca 2+ exchangers (NCX) [98, 99] . According to Seth et al. [98] ] is not found sufficient to start the compensatory expression cycle again (and another wave of Ca 2+ elevation) it could be important in preventing a Ca 2+ -induced permeability transition, which results in swelling and disruption of cardiac mitochondria and release of cytochrome c [115] .
In addition to but independent of the process of increased long-term [ (Figure 4) : first, activation of calcineurin, which is involved in activation of compensatory expression cycle [98, 99] , but also induce mitochondria-dependent apoptosis [3] ; second, activation of some proapoptic MAPKs and inhibition of antiapoptic MAPKs; and third, promotion of proapoptotic Bim/LC8 unbinding from the dynein motor complex and relocation to the mitochondria, where it interacts with Bcl-2 [34, 116] . Which of these three pathways is most harmful for cardiac cells remains to be elucidated. So far, the direct mechanisms underlying the long-term effects of oxysterols have not been investigated substantially in the heart. There is only one paper describing such an effect of cholesterol 5a,6a-epoxide and only on neonatal cardiac cells [27] . However, the data presented in the article only supported the existence of a direct toxic effect of oxysterols on cardiac myocytes. Meanwhile, some indirect data suggest that oxysterols may play a significant role in the development of cardiomyopathy [30] .
Most probable candidates for connecting long-term & rapid effects of oxysterols on cardiac cells
The long-term (mainly morphological) and rapid effects of oxysterols must be connected. In our opinion, the most probable candidates for connecting them are Ca 2+ and MAPKs [15] . Indeed, the fastest effect of oxysterols is to induce an increase in [Ca 2+ ] cyt , and a similar increase in [Ca 2+ ] cyt was demonstrated to affect the activity of all three branches of the MAPK signaling pathway: c-Jun N-terminal kinase (JNK), p38, and extracellular signal-regulated kinase (ERK) [15, 117] . Berthier et al. [34] demonstrated that the activation of ERK by oxysterols is mediated by the Ca 2+ -dependent tyrosine kinase PYK2. Activation or inhibition of certain MAPKs (Figure 5 ) were demonstrated to be responsible for impairing cardiac contractile function, inducing heart hypertrophy and causing apoptotic cell death [5, [82] [83] [84] [85] 87] . One can suggest that like other cell types, an oxysterolinduced increase in [Ca 2+ ] cyt should also influence the activity of MAPKs in cardiac myocytes. MAPKs (p38 and JNK) were d emonstrated to play significant role in a poptosis [5, 85] .
Another way for oxysterols to induce cell death is through the depletion of thapsigarginsensitive Ca 2+ stores (i.e., SR) [15] . Indeed, low SR Ca 2+ load itself was shown to induce apoptosis. There are two hypotheses that can explain the phenomenon of thapsigargin-induced apoptosis [118] . Long-term depletion of the SR Ca 2+ pool might result in: first, disruption of protein processing and transport within the SR/ER; and second, the release of an endonuclease responsible for DNA fragmentation. Alternative pathway for downregulation of protein synthesis leading to cell death is mitochondrial Ca 2+ overload [115, 119] . Thus, the mechanisms connecting oxysterol-induced SERCA inhibition and cell-death remain to be elucidated.
Future perspective
Future research is needed to clarify the mechanisms of atherosclerosis-related contractility disorders in the heart, as well as the pathways leading to atherosclerosis-induced cell death in all tissues located in close proximity to the atherosclerotic core region. New insights into the role of oxysterols in the development of heart complications of atherosclerosis will not only increase our understanding of inflammationinduced heart complications and atherosclerosis progression, but will have practical clinical applications in risk stratification, the targeting of known therapies for the disease, and the d evelopment of new therapeutic strategies.
Conclusion
New findings suggest that the heart muscle can develop dysfunctional Ca 2+ cycling leading to cell death as a result of elevated serum cholesterol derivatives, the oxysterols. This means that oxysterols could be one of the major factors precipitating morbidity in atherosclerosis-induced cardiac diseases and inf lammation-induced heart complications. The ana lysis presented here of current literature permits us to suggest that oxysterols could induce dysfunction of cardiac cells through their effects on the cardiac SR Ca 2+ signaling. Therefore, major efforts should be undertaken in the near future to elucidate the effects of oxysterols on: Ca 2+ handling, Ca 2+ -dependent activity of mitogen-activated protein kinases (MAPKs), and MAPK-related changes of cell u ltrastructure in cardiomyocytes. n Defective SR Ca 2+ cycling is responsible for defective excitation-contraction coupling in heart failure.
Atherosclerosis
n Production of oxysterols occurs in atherosclerotic plaques. n Although functional effects of oxysterols on a number of cell types have been described, their role in the morbidity of atherosclerosis-related cardiac diseases remains unknown.
Heart failure
n Inflammatory processes are directly involved in cardiac depression. n Macrophage oxysterols could be involved in the pathogenesis of early stages of heart failure. n Abnormalities in Ca 2+ handling during heart failure are similar to those caused by oxysterols in muscle cells.
Oxysterol-induced changes in cell ultrastructure & function
n There are fast and long-term effects of oxysterols. n Oxysterols induce a fast Ca 2+ emptying of the SR.
n The type of cell death associated with oxysterol treatment tends to be apoptotic.
Future perspective
n Gaps in our understanding of the mechanisms involved in atherogenesis. 
